Prepaid clinical trial costs (current and non-current)
-22,705
-436,154
Prepaid expenses and other current assets
-99,037
-319,471
Accounts payable
325,332
-1,535,859
Accrued expenses and other current liabilities
-2,511,982
-1,182,338
Net cash used in operating activities
-5,589,486
-13,206,946
Proceeds from issuance of short-term debt
0
0
Repayment of short-term debt
113,246
344,908
Proceeds from issuance of common stock in atm offering, net of transaction costs-The Market Offering Agreement Atm Agreement
312,574
988,112
Proceeds from issuance of common stock, common stock warrants, prefunded warrants and from modification of existing warrants, in offerings, net of transaction costs
8,209,703
9,210,000
Proceeds from exercise of common stock warrants-Common Stock Warrants
0
241,125
Net cash provided by financing activities
8,409,031
10,094,329
Net decrease in cash and cash equivalents
2,819,545
-3,112,617
Cash and cash equivalents at beginning of period
13,476,331
-
Cash and cash equivalents at end of period
13,183,259
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.